Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Is It Time to Join the Party and Double Down on Canopy Growth Stock?

By David Moadel, InvestorPlace Contributor
If anyone's wondering whether Constellation Brands is confident in its CGC stock holdings, here's your answer.

A Reverse Stock Split Was Too Little, Too Late to Save Aurora Cannabis Stock

By InvestorPlace Research Staff
With weak fundamentals, and the potential for shares to drop further, sell Aurora stock and consider better pot plays elsewhere.

Is Aurora Stock Worth Owning After Its Reverse Split?

By David Moadel, InvestorPlace Contributor
The threat of dilution is real so prospective Aurora stockholders might consider other cannabis-sector investments instead.

Canopy Growth Stock has Upside Potential Emerging From This Covid-19 Hole

By Nicolas Chahine, InvestorPlace Contributor
At one point pot stocks were all the rage. CGC stock is trying to make a comeback in spite of the drubbing it took during the Covid-19 crash.

Slimmed-Down Canopy Growth Stock Is a Cannabis Winner

By David Moadel, InvestorPlace Contributor
Investors are punishing CGC stock for cost-cutting measures, but Canopy Growth now is more likely to survive Covid-19 than its bigger peers.

Why Investors Should Bet on Canopy Growth Now as it Readies for Later

By Chris Lau, InvestorPlace Contributor
CGC stock got a lift from production closures worldwide, so as its cost basis shrinks, Canopy Growth will eventually earn profits.

Best ETFs for 2020: The Alternative Harvest ETF Can Escape Virus Damage

By Tim Biggam, InvestorPlace Contributor
The MJ ETF still has a shot at being one of the best ETFs in 2020, as marijuana becomes an essential business during the coronavirus crisis.

Canopy Growth Stock Is the Best Coronavirus Cannabis Play

By Wayne Duggan, InvestorPlace Contributor
Unlike its peers, Canopy Growth has strong fundamentals and an even stronger backer. CGC stock could be a buyout target later this year.

When the Smoke Clears, Canopy Growth Stock Will Be a Winner

By InvestorPlace Research Staff
Cannabis stocks are getting hammered. But the long-term opportunity remains, and CGC stock will remain the sector's leader.

Canopy Growth Stock: No One is Paying 12 Times Sales for Anything

By Dana Blankenhorn, InvestorPlace Contributor
CGC stock has begun laying off people and closing greenhouses, husbanding cash as the coronavirus ravages the stock of its biggest investor, which makes Corona beer.

Aphria Stock Is a Solid Pick for Speculators Amid Market Turmoil

By Tom Taulli, InvestorPlace Contributor
Along with just about every other cannabis stock, Aphria has been in a tailspin. And the implosion of the overall market has made things even worse. But for investors looking for a speculation, this could be a good one.

Cronos Stock Watchers Should Wait For Further Declines Before Buying

By Thomas Niel, InvestorPlace Contributor
Add in the Altria connection, and Cronos stock could be a big winner. But that's over a long time horizon. Until then, the best play is to wait for shares to reach a more reasonable valuation.

Aphria Needs Strong Sales Growth to Rise High Again

By Chris Lau, InvestorPlace Contributor
What does the future look like for Aphria stock? It depends on its success in growing market share and international sales.

Can Aurora Cannabis Climb Its Massive Wall of Worry?

By Sean McCloskey
Aurora stock has a massive wall of worry it has to climb, and I expect more than a few missteps that eventually lead to total collapse.

Don’t Lump OrganiGram Stock With All the Other Downtrodden Pot Stocks

By David Moadel, InvestorPlace Contributor
Even during a challenging time for the broader canna-business, there are still a few good reasons to hold onto OrganiGram stock.

3 Cannabis Stocks That Are Ready to Run

By David Moadel, InvestorPlace Contributor
It is time to sift through the clouds of smoke and take a fresh look at these three cannabis stock picks that are ready to run higher.

Cronos Stock Just Raised a Massive Red Flag

By Wayne Duggan, InvestorPlace Contributor
Cronos has delayed its quarterly and annual earnings report by at least two weeks while it conducts an audit of its financials. Until that audit is complete, the stock will likely underperform.

Patience Will Be Rewarded for Investors in Beaten-Up Cronos Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
It may take awhile for it to materialize, but beaten-up Cronos stock could eventually turn into a multi-bagger for investors.

Approaching $1, Aurora Cannabis Stock Is Not for the Faint of Heart

By Chris Lau, InvestorPlace Contributor
Aurora stock is continuing its downtrend and bullish momentum left the cannabis space. Investors must proceed with caution.
Load More